- Home
- SRTS vs DTF Comparison
SRTS vs DTF Comparison
Compare SRTS & DTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SRTS | DTF |
|---|---|---|
| Founded | 2010 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.5M | 79.8M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | SRTS | DTF |
|---|---|---|
| Price | $4.06 | $11.28 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 170.7K | 21.1K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.64% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.44 |
| Revenue | ★ $35,609,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $47.33 | N/A |
| P/E Ratio | ★ N/A | $24.34 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.03 | $10.29 |
| 52 Week High | $9.31 | $11.19 |
Technical Indicators
Market Signals| Indicator | SRTS | DTF |
|---|---|---|
| Relative Strength Index (RSI) | 53.57 | 44.33 |
| Support Level | $3.81 | $11.27 |
| Resistance Level | $4.34 | $11.35 |
| Average True Range (ATR) | 0.29 | 0.05 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 29.02 | 9.52 |
Price Performance
Historical ComparisonAbout SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
About DTF DTF Tax-Free Income 2028 Term Fund Inc.
DTF Tax-Free Income 2028 Term Fund Inc is a diversified closed-end management investment company. The Fund's investment objective is current income exempt from regular federal income tax consistent with the preservation of capital. It seeks to achieve its investment objective by investing primarily in a diversified portfolio of investment-grade tax-exempt obligations.